Drug recall · March 27, 2013
Carisoprodol Tablets recall
Why: Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Carisoprodol Tablets, USP, 350 mg Rx Only, 100 tablets per bottle, Rx Only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724, NDC 0143-1176-01.
- Lots / codes
Lot #: 69160A
- Quantity
- 1763 bottles
- Company
- West-ward Pharmaceutical Corp., Eatontown, NJ
- Distribution
- Nationwide
- Initiated
- November 30, 2012 · Voluntary: Firm initiated
- Classified
- March 15, 2013
- Reported
- March 27, 2013
- Ended
- December 18, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carisoprodol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.